Abstract:Aims: The aim of this study was to characterize the metabolites associated with small- and large-gestational-age newborns in maternal and cord blood, and to investigate potential mechanisms underlying the association between birthweight and metabolic disturbances. Research design and methods: We recorded detailed anthropometric data of mother-offspring dyads. Untargeted metabolomic assays were performed on 67 pairs of cord blood and maternal fasting plasma samples including 16 pairs of small-for-gestational (SGA, < 10th percentile) dyads, 28 pairs of appropriate-for-gestational (AGA, approximate 50 percentile) dyads, and 23 pairs of large-for-gestational (LGA, > 90th percentile) dyads. The association of metabolites with newborn birthweight was conducted to screen for metabolites with U-shaped and line-shaped distributions. The association of metabolites with maternal and fetal phenotypes was also performed. Results: We found 2 types of metabolites that changed in different patterns according to newborn birthweight. One type of metabolite exhibited a "U-shaped" trend of abundance fluctuation in the SGA-AGA-LGA groups. The results demonstrated that cuminaldehyde level was lower in the SGA and LGA groups, and its abundance in cord blood was negatively correlated with maternal BMI (r = -0.352 p = 0.009) and weight gain (r = -0.267 p = 0.043). 2-Methoxy-estradiol-17b 3-glucuronide, which showed enrichment in the SGA and LGA groups, was positively correlated with homocysteine (r = 0.44, p < 0.001) and free fatty acid (r = 0.42, p < 0.001) in maternal blood. Serotonin and 13(S)-HODE were the second type of metabolites, denoted as "line-shaped", which both showed increasing trends in the SGA-AGA-LGA groups in both maternal and cord blood and were both significantly positively correlated with maternal BMI before pregnancy. Moreover, cuminaldehyde, serotonin, 13(S)-HODE and some lipid metabolites showed a strong correlation between maternal and cord blood. Conclusions: These investigations demonstrate broad-scale metabolomic differences associated with newborn birthweight in both pregnant women and their newborns. The U-shaped metabolites associated with both the SGA and LGA groups might explain the U-shaped association between birthweight and metabolic dysregulation. The line-shaped metabolites might participate in intrauterine growth regulation. These observations might help to provide new insights into the insulin resistance and the risk of metabolic disturbance of SGA and LGA babies in adulthood and might identify potential new markers for adverse newborn outcomes in pregnant women.

Umbilical cord blood metabolomics: association with intrauterine hyperglycemia

Long-term Outcomes and Potential Mechanisms of Offspring Exposed to Intrauterine Hyperglycemia

Genome-wide DNA Methylation Profiling in Infants Born to Gestational Diabetes Mellitus

Epigenetic Alteration of Rho Guanine Nucleotide Exchange Factor 11 (ARHGEF11) in Cord Blood Samples in Macrosomia Exposed to Intrauterine Hyperglycemia

Metabolic Biomarkers of Monochorionic Twins Complicated with Selective Intrauterine Growth Restriction in Cord Plasma and Placental Tissue

Biochemical profiling study in umbilical cord blood in mothers with metabolic disorders

The influence of maternal prepregnancy weight and gestational weight gain on the umbilical cord blood metabolome: a case–control study

Study on the relationship between selective intrauterine growth restriction (sIUGR) and metabolic disorder-Metabonomics Study of cord blood based on gas chromatography time-of-flight mass spectrometry (GC-TOF/MS)

Altered DNA methylation in neonates born large-for-gestational-age is associated with cardiometabolic risk in children.

Increased Methylation at Differentially Methylated Region of GNAS in Infants Born to Gestational Diabetes

Decreased Fetal Pre-Adipocyte Factor-1 in Pregnancies Complicated by Gestational Diabetes Mellitus

Nontargeted metabolomics reveals the potential mechanism underlying the association between birthweight and metabolic disturbances

Preliminary analysis of metabonomics in selective intrauterine growth restriction with abnormal umbilical artery Doppler flow

Cord Blood Fetuin-B, Fetal Growth Factors and Lipids in Gestational Diabetes Mellitus

Atlas of fetal metabolism during mid-to-late gestation and diabetic pregnancy

Gestational diabetes mellitus decreased umbilical cord blood polyunsaturated fatty acids: a meta-analysis of observational studies

Proteomics and bioinformatics analysis of cardiovascular related proteins in offspring exposed to gestational diabetes mellitus

Metabolic profiles in gestational diabetes mellitus can reveal novel biomarkers for prediction of adverse neonatal outcomes

The landscape of fetus metabolism in maternal hyperglycemia

Landscapes of maternal and neonatal gut microbiome and plasma metabolome signatures and their interaction in gestational diabetes mellitus

Associations between nutrients in one-carbon metabolism and fetal DNA methylation in pregnancies with or without gestational diabetes mellitus